Professional Documents
Culture Documents
CADD Feb 10 DR MB
CADD Feb 10 DR MB
CADD
MB
Dr Mahmoud Bakr ١
Contents
What is drug design?
Dr Mahmoud Bakr ٢
Drug Design
¾ Design is a programmed search for an object.
Dr Mahmoud Bakr ٣
Strategies in Drug Design
(1) Classical DD
Molecular Modification of lead
The oldest
Dr Mahmoud Bakr ٤
Molecular Modification of Prototype
Testing
New Drug
Dr Mahmoud Bakr ٥
Strategies in Drug Design
Dr Mahmoud Bakr ٦
Rational Drug Design
The goal of the approaches is to increase the chance
of finding a useful compound.
This means that new structure can be developed with
high probability of possessing the required biological
property.
With the advances in Molecular Biology and
Computer sciences, “rational” approaches to drug
design have become more popular and important.
Dr Mahmoud Bakr ٧
Computer era
Today’s workshop
To examine the role of computers in drug design .
CADD
Dr Mahmoud Bakr ٨
Computers. What for?
It comprises:
Molecular Graphics
Computational Chemistry
Dr Mahmoud Bakr ٩
Molecular Graphics
Dr Mahmoud Bakr ١٠
Computational Chemistry
Dr Mahmoud Bakr ١١
Molecular Modeling
Uses of Programs that can generate 3-D structures,
visualize, calculate, compute and minimize energy,
examine the conformations available to a compound,
integrate data, and manipulate all the obtained
information.
Create models of molecules, models of biological
binding sites and even models of drug-receptor (D-R)
complex are provided.
Dr Mahmoud Bakr ١٢
What is a Model?
Hand-held Models
Computer Graphic model
Dr Mahmoud Bakr ١٣
What Computers can do
1. Representation of molecules
Generation of 3-D of small molecules (drugs and candidates) from
two-dimensional formulae.
Label atoms and stereochemistry
Generation of 3D structures of large molecules (receptors or
enzymes)
Definition of the bond distances & bond angles within molecules.
Generation of all conformers.
Representation of the space-filling models, VdW, electronic charge
distribution, ……
Manipulation of structures (by allowing rotation of all models on١٤ the
Dr Mahmoud Bakr
e.g. Epinephrine
Mol Formula C9H13NO3
OH
HO NHCH3
HO
Dr Mahmoud Bakr ١٥
Computer Graphic Displays (Visualization)
Dr Mahmoud Bakr ١٦
3D structure of Epinephrine
OH
HO NHCH3
HO Build 3D
model
Dr Mahmoud Bakr ١٧
Different methods of visualizing Epinephrine
Dr Mahmoud Bakr ١٩
Partial charges of histamine
Dr Mahmoud Bakr ٢٠
What computers can do
Dr Mahmoud Bakr ٢١
What computers can do
In computational chemistry,
major techniques are applied:
Dr Mahmoud Bakr ٢٢
Molecular Dynamics
Dr Mahmoud Bakr ٢٣
Molecular Dynamics
3. Development of models
Development of models (optimized structures) of both small
molecules (Drugs or candidates) and macromolecules
(enzymes or receptor sites).
Allow binding of small molecules to macromolecules .
Calculate energy of interaction. The lowest possible energy
reflects the highest stability of the complex and hence, the
highest fitting pattern between drug and macromolecule.
Comparison of designed complexes
Analysis of data. Dr Mahmoud Bakr ٢٥
What computers can do
4. Final goals
Prediction of the biological activity of
“theoretical” molecules.
Design of new drugs: modified or from scratch
“de novo”
Identification of the Pharmacophore
Mapping of receptor sites.
Dr Mahmoud Bakr ٢٦
Methodology
Dr Mahmoud Bakr ٢٧
SBDD
Dr Mahmoud Bakr ٢٨
Great Advances
PDB
Dr Mahmoud Bakr ٢٩
SBDD
Receptor-fit approach
theoretical calculation.
Dr Mahmoud Bakr ٣٠
SBDD
With the structure of the target protein-ligand complex, one can:
…….. … and …
Dr Mahmoud Bakr ٣٣
SBDD
2. Identification of the 3D
structure of the active site..
Dr Mahmoud Bakr ٣٤
SBDD
3. Characterization of the active
conformation of the site
Dr Mahmoud Bakr ٣٥
SBMD
4. Design of ligands (small molecules as
potential or candidate drug)
Dr Mahmoud Bakr ٣٦
SBDD
5. Docking of small molecules into binding site:
Alignment of the molecules in the active site model.
The newly designed molecules have to complement precisely the
known binding sites of the target molecule.
The selected ligand should posses the appropriate geometry to fit
into the binding site of the target molecule, with minimal steric
clashes (i.e. tight fitting).
Also, favorable interaction between the chemical groups in the
binding site and the designed compound should be achieved.
i.e. the best fitting means not only complementary shapes but also
favorable energy of interaction.
Dr Mahmoud Bakr ٣٧
SBDD
Dr Mahmoud Bakr ٣٨
SBDD
Dr Mahmoud Bakr ٣٩
SBDD
Dr Mahmoud Bakr ٤٠
SBDD
Dr Mahmoud Bakr ٤١
SBDD. examples
There are numerous programs that have been applied
successfully in the following fields:
ACE inhibitors
DHFR inhibitors
Dr Mahmoud Bakr ٤٣
Indinavir
Inhibitors of (HIV-1) protease.
Dr Mahmoud Bakr ٤٤
DNA as a receptor
Dr Mahmoud Bakr ٤٥
Ligand-Based Design
Small Molecule Design
The binding macromolecule is unknown
Dr Mahmoud Bakr ٤٦
Small Molecule Design
Dr Mahmoud Bakr ٤٧
Ligand-Based Design: 3D-QSAR
Dr Mahmoud Bakr ٤٨
CoMFA
A combination of structural modeling (3D- and energy
calculations) and QSAR.
In this method, the steric and electrostatic properties
are represented in 3D maps and correlated with the
biological activity.
Using this 3D-QSAR technique, medicinal chemists can
predict the potency of a not-yet synthesized compound
(i.e. the hypothetical drug).
Dr Mahmoud Bakr ٤٩
CoMFA
OH
HO NHCH3
HO
Build 3D
model
Active conformation Define pharmacophore
Dr Mahmoud Bakr ٥٠
CoMFA
Dr Mahmoud Bakr ٥١
CoMFA Publications
Ablordeppey SY, El-Ashmawy MB, Glennon RA.
Analysis of the structure-activity relationships of sigma
receptor ligands. Med. Chem. Res., 1991, 1, 425-438.
Dr Mahmoud Bakr ٥٢
CADD Software
AutoDock Automated Docking of Flexible Ligands to
Macromolecules
Chem3D from CambridgeSoft
MM2, Discover,
DGeom, Disco
Dock, fit
Molegro
Dr Mahmoud Bakr ٥٤
Uses of Computer. Summary
visualization of structures,
Dr Mahmoud Bakr ٥٥
Quetions?
Thank U
Dr Mahmoud Bakr ٥٦